New heart valve device could change treatment for moderate aortic stenosis
NCT ID NCT07532317
First seen Apr 17, 2026 · Last updated May 24, 2026 · Updated 8 times
Summary
This study compares a new heart valve device (Myval) to standard medication in 778 people aged 65+ with moderate aortic stenosis, a condition where the heart's main valve narrows. Participants will be randomly assigned to receive either the valve implant or medication alone. The goal is to see which approach better prevents death, stroke, heart failure, and decline in quality of life over two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.